Last reviewed · How we verify
Betamethasone Dipropionate 0.05% Cream
Betamethasone Dipropionate 0.05% Cream is a Corticosteroid Small molecule drug developed by Padagis LLC. It is currently in Phase 2 development for Seborrheic dermatitis, Psoriasis. Also known as: Betamethasone Dipropionate.
Betamethasone dipropionate is a corticosteroid that reduces inflammation and suppresses the immune system.
Betamethasone dipropionate is a corticosteroid that reduces inflammation and suppresses the immune system. Used for Seborrheic dermatitis, Psoriasis.
At a glance
| Generic name | Betamethasone Dipropionate 0.05% Cream |
|---|---|
| Also known as | Betamethasone Dipropionate |
| Sponsor | Padagis LLC |
| Drug class | Corticosteroid |
| Modality | Small molecule |
| Therapeutic area | Dermatology |
| Phase | Phase 2 |
Mechanism of action
It works by inhibiting the production of inflammatory mediators and reducing the activity of immune cells. This leads to a decrease in swelling, redness, and pain in affected areas.
Approved indications
- Seborrheic dermatitis
- Psoriasis
Common side effects
- Skin irritation
- Allergic contact dermatitis
- Folliculitis
Key clinical trials
- Comparison of Post-Inflammatory Pigment Alteration After Psoriasis Treatment (PIPA - Dermavant) (PHASE2, PHASE3)
- A Clinical Trial to Compare Topical Agents in Adults With Mild to Moderate Atopic Dermatitis (AD) (PHASE1)
- A Study of Ruxolitinib Phosphate Cream When Applied to Patients With Plaque Psoriasis (PHASE2)
- Randomized Study to Compare the Bioavailability of Two Augmented Betamethasone Dipropionate 0.05% Topical Creams
- Phototherpy Versus Tapwater Iontophoresis for Management of Atopic Dermatitis in Children. (NA)
- Evaluation of the Vasoconstriction Properties of MC2-01 Cream (PHASE1)
- Vasoconstriction Trial With LEO 90100 Aerosol Foam (PHASE1)
- BAY1003803 Formulation Comparison in Open Psoriasis Plaque Test (PHASE1)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape:
- Betamethasone Dipropionate 0.05% Cream CI brief — competitive landscape report
- Betamethasone Dipropionate 0.05% Cream updates RSS · CI watch RSS
- Padagis LLC portfolio CI
Frequently asked questions about Betamethasone Dipropionate 0.05% Cream
What is Betamethasone Dipropionate 0.05% Cream?
How does Betamethasone Dipropionate 0.05% Cream work?
What is Betamethasone Dipropionate 0.05% Cream used for?
Who makes Betamethasone Dipropionate 0.05% Cream?
Is Betamethasone Dipropionate 0.05% Cream also known as anything else?
What drug class is Betamethasone Dipropionate 0.05% Cream in?
What development phase is Betamethasone Dipropionate 0.05% Cream in?
What are the side effects of Betamethasone Dipropionate 0.05% Cream?
Related
- Drug class: All Corticosteroid drugs
- Manufacturer: Padagis LLC — full pipeline
- Therapeutic area: All drugs in Dermatology
- Indication: Drugs for Seborrheic dermatitis
- Indication: Drugs for Psoriasis
- Also known as: Betamethasone Dipropionate
- Compare: Betamethasone Dipropionate 0.05% Cream vs similar drugs
- Pricing: Betamethasone Dipropionate 0.05% Cream cost, discount & access